ZLB Plasma Services and TeleVox Work Together To Call On Plasma Donors
TeleVox Software and ZLB Plasma Services are working together to implement a pilot study in two of its plasma collection centers. This study will look at the overall effectiveness of donor recruitment reminder calls to plasma donors.
ZLB Plasma Services will be testing this automated voice program from TeleVox Software that reminds inactive plasma donors to come back and donate plasma.
According to Scott Newkirk, Director of Donor Relations, �Our plans are to pilot in two centers to test the feasibility of the TeleVox program. If all works well, we will expand the pilot for all U.S. centers and use the program to further enhance customer service. It will also be a means to communicate promotional information to our current plasma donors.�
He added, �With TeleVox, we hope to reach many more donors and to get them back into the ZLB Plasma Services� family of donors. The patients who rely on plasma- derived therapies are counting on us to supply needed plasma. We are looking forward to working with TeleVox in the pilot study.�
About TeleVox Software, Inc.:
TeleVox Software, Inc., based in Mobile, AL, is a leading provider of communication solutions for the blood services industry. With over 13 years of experience, TeleVox offers a full range of products, including outbound messaging, donor outreach programs, data append services and survey delivery systems. Supported by a state-of- the-art infrastructure, TeleVox solutions resolve time-consuming communication issues associated with appointment reminders and recruitment appeals. TeleVox has a worldwide presence in over 12,000 organizations and delivers millions of messages weekly via telephone and the Internet.
About ZLB Plasma Services:
ZLB Plasma Services, one of the largest collectors of human plasma in the world, is dedicated to the collection of plasma for life-saving therapies. ZLB Plasma Services operates plasma collection centers across the United States and in Germany.
The Company is part of the ZLB Behring group that is owned by CSL Limited, based in Australia. ZLB Behring was formed when CSL acquired Aventis Behring (and Aventis Bio-Services). The group has a proud heritage dating back to the scientific efforts of Nobel Prize winner Emil von Behring and the renowned efforts of the Swiss Red Cross.
CSL was founded in Melbourne, Australia in 1916 to supply vaccines for the Australian Government. It became a private company listed on the Australian Stock Exchange in 1994. CSL Limited has grown rapidly through strategic acquisitions and investment to become a successful global specialty biopharmaceutical company with over 7000 employees.
For more information, go to: